Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

MLA

Foley, Michael J., et al. “Coronary Sinus Reducer for the Treatment of Refractory Angina (ORBITA-COSMIC): A Randomised, Placebo-Controlled Trial.” The Lancet, vol. 403, no. 10436, Apr. 2024, pp. 1543–53. EBSCOhost, https://doi.org/10.1016/S0140-6736(24)00256-3.

APA

Foley, M. J., Rajkumar, C. A., Ahmed-Jushuf, F., Simader, F. A., Chotai, S., Pathimagaraj, R. H., Mohsin, M., Salih, A., Wang, D., Dixit, P., Davies, J. R., Keeble, T. R., Cosgrove, C., Spratt, J. C., O, K. P. D., De Silva, R., Hill, J. M., Nijjer, S. S., Sen, S., … Al-Lamee, R. K. (2024). Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial. The Lancet, 403(10436), 1543–1553. https://doi.org/10.1016/S0140-6736(24)00256-3

Chicago

Foley, Michael J, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, Florentina A Simader, Shayna Chotai, Rachel H Pathimagaraj, Muhammad Mohsin, et al. 2024. “Coronary Sinus Reducer for the Treatment of Refractory Angina (ORBITA-COSMIC): A Randomised, Placebo-Controlled Trial.” The Lancet 403 (10436): 1543–53. doi:10.1016/S0140-6736(24)00256-3.